Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B
- 31 December 2005
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 84 (6) , 1685-1688
- https://doi.org/10.1016/j.fertnstert.2005.06.026
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatmentFertility and Sterility, 2005
- Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transitionMenopause, 2004
- Müllerian-inhibiting substance in women with polycystic ovary syndrome: Relationship with hormonal and metabolic characteristicsFertility and Sterility, 2004
- Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertilityHuman Reproduction, 2004
- Anti-Müllerian hormone and its role in ovarian functionMolecular and Cellular Endocrinology, 2003
- Ultrasound assessment of the polycystic ovary: international consensus definitionsHuman Reproduction Update, 2003
- Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In HumansJournal of Clinical Endocrinology & Metabolism, 2000
- Mid-Follicular Phase Pulses of Inhibin B Are Absent in Polycystic Ovarian Syndrome and Are Initiated by Successful Laparoscopic Ovarian Diathermy: A Possible Mechanism Regulating Emergence of the Dominant FollicleJournal of Clinical Endocrinology & Metabolism, 1998
- Is 11β-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate?American Journal of Obstetrics and Gynecology, 1991
- MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONEThe Lancet, 1985